Dapsone in Behçet's Disease: A Double‐Blind, Placebo‐Controlled, Cross‐Over Study

@article{Sharquie2002DapsoneIB,
  title={Dapsone in Behçet's Disease: A Double‐Blind, Placebo‐Controlled, Cross‐Over Study},
  author={K. Sharquie and R. Najim and Ahmed R. Abu-raghif},
  journal={The Journal of Dermatology},
  year={2002},
  volume={29}
}
The study was designed to investigate the effects of dapsone in the treatment of mucocutaneous manifestations of Behçet's disease and the possible prophylactic role of dapsone in a double blind/placebo controlled clinical trial. Twenty patients diagnosed according to the International Study Group criteria as Behçet's disease were included in the study. Patients were randomly allocated to receive either dapsone 100 mg daily or placebo for three months in a double‐blind manner. After three months… Expand
View on Wiley
ncbi.nlm.nih.gov
119 Citations
Highly Influential Citations
4
Background Citations
23
Results Citations
1

Paper Mentions

Interventional Clinical Trial
Clinical Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia
This study is to assess the impact on the prevention of sarcopenia after taking cetylpyridinium chloride targeting the patients of pre-sarcopenia or sarcopenia over the age of 60… Expand
ConditionsSarcopenia
InterventionDrug
Seoul National University Hospital
October 2015 - August 2016
Interventional Clinical Trial
Preventive Effects of Cetylpyridinium Chloride on SarcopeniaStudy
This study is to assess the impact on the prevention of sarcopenia after taking cetylpyridinium chloride targeting the patients of presarcopenia over the age of 60.  
ConditionsSarcopenia
InterventionDrug
Seoul National University Hospital
November 2014 - November 2015

119 Citations

Citation Type

Citation Type

A double-blind trial of depot corticosteroids in Behçet's syndrome.
  • 83
  • PDF
Oral zinc sulfate in the treatment of Behcet's disease: A double blind cross‐over study
  • 37
Old and New Treatment for Behçet’s Disease
New Evidence-Based Treatment Approach in Behçet's Disease
  • E. Alpsoy
  • Medicine
  • Pathology research international
  • 2012
  • 41
  • Highly Influenced
  • PDF
Experimental Therapeutic Solutions for Behcet’s Disease
  • PDF
The challenging treatment of Behcet’s disease
Acetylator Phenotype in Behçet's Disease
  • 2
Medical Management of Behçet’s Syndrome
  • 1
Treatment of Behcets disease
  • 7
Treatment of Behçet’s disease
  • 5
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 27 REFERENCES
Behçet's disease and complex aphthosis.
  • 63
Histological and direct immunofluorescence study of cutaneous hyperreactivity in Behçet's disease
  • 56
Sensitivity and specificity of different diagnostic criteria for Behçet's disease according to the latent class approach.
  • 34
The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. A possible mechanism in the treatment of dermatitis herpetiformis.
  • 161
  • PDF
Skin window examination according to Rebuck and cutaneous pathergy tests in patients with Behcet's disease.
  • 8
Leucocyte movement and colchicine treatment in Behcet's disease
  • 167
Suppression of Behçe?s disease with dapsone
  • K. Sharquie
  • Medicine
  • The British journal of dermatology
  • 1984
  • 62
In vitro and in vivo effects of dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy.
  • 55
  • PDF
Effects of potassium iodide, colchicine and dapsone on the generation of polymorphonuclear leukocyte‐derived oxygen intermediates
  • 107
Studies on the Inhibitory Effects of Analogues of Dapsone on Neutrophil Function In‐vitro*
  • 19
...
1
2
3
...